 Passage Bio NASDAQ:PASG was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued to investors on Friday, Zacks.com reports. The brokerage currently has a 18.00 price target on the stock. Zacks Investment Researchs price target would suggest a potential upside of 5.39 from the stocks current ... 